Skip to content

Clinical trials

Liver Diseases trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20141
20151
20161
20191
20201
20211
20221
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Mirum Pharmaceuticals, Inc.2
National Cancer Centre, Singapore2
Novartis Pharmaceuticals2
Abbott1
AusperBio Therapeutics Inc.1
Blueprint Medicines Corporation1
Boehringer Ingelheim1
Imunon1
National University Hospital, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases14
Digestive System Diseases8
Carcinoma, Hepatocellular5
Fibrosis3
Liver Neoplasms3
Neoplasms3
Adenocarcinoma2
Bile Duct Diseases2
Biliary Tract Diseases2
Carcinoma2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.